Fulgent Genetics's total assets for Q1 2026 were $1.16B, a decrease of -4.71% from the previous quarter. FLGT total liabilities were $112.22M for the fiscal quarter, a 5.06% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.